TrialClinical pharmacology and therapeutics2026

Epcoritamab Step-Up Dosing Regimen Selection and Optimization Using Repeated Time-to-Event Modeling for Cytokine Release Syndrome Risk Mitigation.

Tommy Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.